Efficacy, survival and safety of selinexor, bortezomib and dexamethasone (SVd) in patients with lenalidomiderefractory multiple myeloma: subgroup data from the BOSTON Trial
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
bortezomib,lenalidomide-refractory
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要